Covered recipient · General Payments record
ELIZABETH C POWELL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$910.96
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $311.66 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $81.51 | 5 |
| ABBVIE INC. | $54.44 | 3 |
| DEXCOM, INC. | $52.86 | 2 |
| Gilead Sciences, Inc. | $30.38 | 1 |
| Exact Sciences Corporation | $29.03 | 1 |
| Merck Sharp & Dohme Corporation | $26.95 | 2 |
| Phadia US Inc. | $20.58 | 1 |
| Alkermes, Inc. | $15.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.63 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108034998 | CMS |
| ABBVIE INC. | $17.62 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108035000 | CMS |
| ABBVIE INC. | $21.19 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108035002 | CMS |
| Alkermes, Inc. | $15.91 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120575433 | CMS |
| Dexcom, Inc. | $22.24 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153359319 | CMS |
| Dexcom, Inc. | $30.62 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153359321 | CMS |
| Exact Sciences Corporation | $29.03 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114437604 | CMS |
| Gilead Sciences, Inc. | $30.38 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133689437 | CMS |
| Lilly USA, LLC | $14.71 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135635996 | CMS |
| Lilly USA, LLC | $16.66 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135635998 | CMS |
| Lilly USA, LLC | $16.51 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135636000 | CMS |
| Lilly USA, LLC | $17.96 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135618289 | CMS |
| Lilly USA, LLC | $15.67 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135618291 | CMS |
| Merck Sharp & Dohme LLC | $13.84 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141942889 | CMS |
| Merck Sharp & Dohme LLC | $13.11 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141974486 | CMS |
| Phadia US Inc. | $20.58 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067578406 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.